GastroPlus® version 9.8 has the most innovative & integrative software improvements to accelerate drug development through...
What’s New in DSX™
DILIsym is quantitative systems toxicology (QST) software that integrates in vitro mechanistic data and PBPK predictions of drug concentration in the...
The UofA Faculty of Pharmacy & Pharm.Sci presents Phytocannabinoids DDIs and more!
Cannabis is a plant with a long history of human pharmacological use, both for recreational purposes and as a medicinal remedy.
GastroPlus® Tutorial: Phase 2 Video 1: How to create a new PBPK physiology in GastroPlus
This video will focus on how to create a new PBPK physiology in GastroPlus.
GastroPlus® Tutorial: Phase 2 Video 2: How to set up metabolic clearance using in vitro data
In this video we will show you how to set up metabolic clearance using in vitro data.
MonolixSuite: What’s new in 2020?
MonolixSuite’s latest release (2020) introduces a new application for clinical trial simulations, with a user-friendly interface and interactive plots.
Delivering on the promise of AI-driven drug discovery with ADMET Predictor® 10 (APX). Background and applications examples
Dr. Marvin Waldman will present a brief background behind generative chemistry applications and their relevance to ADMET Predictor® (APX).
Part 2 – Utilization of PBBM/PBPK Models for Building a Safe Space with Dr. Sandra Suarez-Sharp
The GastroPlus User Group and Dr. Sandra Suarez-Sharp follow up on the questions asked during Part 1 of, "Utilization of PBBM/PBPK Models for Building a Safe Space and Regulatory Applications in Support of Drug Product Quality."
ADMET Predictor® 10 (APX): Multi-threaded property prediction, new transporter models, AI-driven drug discovery and more
Eric Jamois, Director of Business Development, will host a webinar on Wednesday, September 16th to introduce the new ADMET Predictor® 10 (APX) release.
DILIsym: Modeling Drug-Induced Liver Injury & Beyond
DILIsym Services, Inc. (DSSI) is a Simulations Plus company...
QST Applications, Use of Data and Species Differences
DILIsym Services, Inc. (DSSI) is a Simulations Plus company..
GastroPlus® Lecture Series Part III: DDI Predictions with Viera Lukacova
This GastroPlus® webinar hosted by Viera Lukacova, Director of Simulation Sciences, provides an overview of modeling and simulation in DDI risk...
GastroPlus® Lecture Series Part II: Mechanistic IVIVCs and Virtual BE trial simulations
This GastroPlus® webinar hosted by Joyce Macwan, Sr. Scientist II, provides an overview of mechanistic IVIVC and virtual bioequivalence trials to support formulation development.
GastroPlus® Lecture Series Part I Basic model considerations & food effect predictions
In this GastroPlus® webinar hosted by Principal Scientist Jim Mullin explores updated human exposure predictions and food effect risk identification using...
DILIsym Simulations Support the Liver Safety of Ubrogepant in New Toxicological Sciences Publication
Dr. Paul B. Watkins and Dr. Jeff Woodhead discuss the DILIsym analysis of the latest publication in Toxicological Sciences! Small-molecule calcitonin gene...
GastroPlus® Tutorial: Phase 1: Video 3: Support files and loading your data into GastroPlus
This video is dedicated to support files and how to load your data in GastroPlus.
GastroPlus® Tutorial: Phase 1: Video 2: How to start a PBBM PBPK project in GastroPlus
In this video we'll show you how to start a project with GastroPlus.
How To Improve Your Compound Design & Screening Using ADMET Property Prediction and PK Simulations Day 2
Simulations Plus, in partnerships with pharmaceutical companies globally, has made significant investments in its ADMET Predictor® platform to implement...
GastroPlus® Tutorial: Phase 1: Prediction of plasma concentration
The goal is to predict the plasma concentration time following intravenous administration using a compartmental model.
How To Improve Your Compound Design & Screening Using ADMET Property Prediction and PK Simulations Day 1
Simulations Plus, in partnerships with pharmaceutical companies globally, has made significant investments in its ADMET Predictor® platform to implement...